Kelly Shi
Stock Analyst at Jefferies
(2.90)
# 1,291
Out of 5,182 analysts
35
Total ratings
41.18%
Success rate
11.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Assumes: Buy | $252 → $290 | $235.90 | +22.93% | 3 | Mar 16, 2026 | |
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $8.38 | +7.40% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $86.26 | +41.43% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $66.57 | +15.67% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $137.09 | +7.96% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $35.87 | -21.94% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $17.85 | +146.50% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $6.01 | +149.58% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $8.01 | +549.19% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.68 | +199.15% | 2 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $19 | $39.60 | -52.02% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $12.39 | +69.49% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $20.65 | +79.18% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $1.96 | +206.12% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $99.85 | -18.88% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $29.62 | +18.16% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.73 | +865.15% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $17.70 | -9.60% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $20.39 | -1.91% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $8.55 | +4,952.63% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $13.43 | +287.19% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.48 | +988.71% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $3.62 | +811.60% | 1 | Mar 8, 2021 |
Ascendis Pharma
Mar 16, 2026
Assumes: Buy
Price Target: $252 → $290
Current: $235.90
Upside: +22.93%
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $8.38
Upside: +7.40%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $86.26
Upside: +41.43%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $66.57
Upside: +15.67%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $137.09
Upside: +7.96%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $35.87
Upside: -21.94%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $17.85
Upside: +146.50%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $6.01
Upside: +149.58%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $8.01
Upside: +549.19%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.68
Upside: +199.15%
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $39.60
Upside: -52.02%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $12.39
Upside: +69.49%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $20.65
Upside: +79.18%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $1.96
Upside: +206.12%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $99.85
Upside: -18.88%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $29.62
Upside: +18.16%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $3.73
Upside: +865.15%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $17.70
Upside: -9.60%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $20.39
Upside: -1.91%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $8.55
Upside: +4,952.63%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $13.43
Upside: +287.19%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.48
Upside: +988.71%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $3.62
Upside: +811.60%